POSTED 08 July 2020

Joint announcement by Veryan and Walk Vascular

Walk Vascular, LLC (Irvine, CA) and Veryan Medical (Horsham, UK) have announced that Veryan Medical will support Walk Vascular in the commercialization of the innovative JETi Peripheral Thrombectomy System in Germany.

08 July 2020

Walk Vascular’s JETi Thrombectomy System employs an internal jet, located safely just inside its catheter mouth, capable of engaging large thrombus volumes through a miniature lumen, rapidly clearing peripheral vessels that can often prove challenging for standard aspiration devices.

“By working with Veryan Medical we can hit the ground running” comments David Look, President and CEO of Walk Vascular. “Veryan provides an invaluable catalyst to our commercial efforts, providing access to key opinion leaders in Germany through an experienced sales team with clinical expertise.”

“We are pleased to be working with Walk Vascular and the JETi technology, a proven solution that safely and effectively restores blood flow in peripheral thrombectomy procedures,” says Nick Yeo, Veryan Medical’s CEO. “We are proud to support innovators like Walk Vascular to provide insights, marketing strategy, and a top-tier salesforce to ensure commercial success and clinical adoption. JETi and Veryan’s novel BioMimics 3D stent are an exciting combination both for our sales team and our customers.”


About the JETi 88 Peripheral Thrombectomy System

 The JETi Thrombectomy System is intended to remove/aspirate fluid and break-up soft emboli and thrombus from the peripheral vasculature and to sub selectively infuse/deliver diagnostics or therapeutics with or without vessel occlusion.

About Walk Vascular

Headquartered in Irvine, CA, Walk Vascular is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from peripheral vascular thromboembolic disease. The current product offering consists of a novel catheter-based solution that blends an efficacious mix of power and precision. JETi Catheters commercialized today are CE Marked and FDA-cleared, are indicated for the breakup and removal of clot within the peripheral vasculature and are used to treat patients suffering from peripheral arterial occlusions (PAO) and deep vein thrombosis (DVT).

Walk Vascular, LLC, Inc., JETi, logos and other registered or common law trade names and trademarks are the property of Walk Vascular. Information on the JETi Registry can be found at under NCT#04370691.


About Veryan Medical

Veryan became an Otsuka Medical Devices company in December 2018 and applies design intelligence derived from a combination of imagination, intuition and innovation to the development and marketing of interventional medical devices. Veryan’s Head Office is in Horsham, UK, its Innovation Research & Development facility is in Galway, Ireland and it has direct sales teams in Germany and the US. Veryan’s primary proprietary product is the BioMimics 3D Vascular Stent System which has approval in US, Japan and Europe.

BioMimics 3D and Swirling Flow are registered trademarks of Veryan Medical Ltd


For more information:

Walk Vascular                                                               
David Look, President and CEO               


Veryan Medical

Vanessa Lee, Marketing Director